Buoyancy and drug release patterns of floating minitablets containing piretanide and atenolol as model drugs

Pharmaceutical Development and Technology

Volumn 3, Issue 1, 1998, Pages 73-84

  Rouge, Nathalie ^a   Cole, Ewart T ^b   Doelker, Eric ^a   Buri, Pierre ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b CAPSUGEL   (France)

Author keywords

Atenolol; Drug release; Floating dosage form; Minitablets; Multiple unit dosage form; Piretanide

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; ATENOLOL; BETA CYCLODEXTRIN; BICARBONATE; EUDRAGIT; GELATIN; HYDROXYPROPYLCELLULOSE; HYDROXYPROPYLMETHYLCELLULOSE; MACROGOL 6000; METHOCEL A4M; METHOCEL E4M; METHOCEL F4M; METHYLCELLULOSE; PIRETANIDE; POVIDONE; POVIDONE K25; UNCLASSIFIED DRUG;

AREA UNDER THE CURVE; ARTICLE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; PRIORITY JOURNAL; SUSTAINED DRUG RELEASE; TABLET; TABLET COMPRESSION; TABLET DISINTEGRATION TIME; TABLET POROSITY; VISCOSITY;

EID: 0031799882     PISSN: 10837450     EISSN: None     Source Type: Journal    
DOI: 10.3109/10837459809028481     Document Type: Article

References (28)

1. J. Timmermans and A. J. Moës, Factors controlling the buoyancy and gastric retention capabilities of floating matrix capsules: new data for reconsidering the controversy, J. Pharm. Sci., 83, 18-24 (1994).
2. E. Doelker, Novel methods of producing controlled release hard gelatin capsules, Proceedings Capsugel Symposium, Hamburg, 7-15 (1988).
3. G. Bongiovanni, M. Calanchi, and M. Marconi, Multiparticulate sustained release matrix system, International Patent Application A61K9/48,9/20, 1-13 (1992).
4. N. Follonier and E. Doelker, Biopharmaceutical comparison of oral multiple-unit and single-unit sustained-release dosage forms, S. T. P. Pharma, 2, 141-158 (1992).
5. Y. Kawashima, T. Niwa, H. Takeuchi, T. Hino, and Y. Itoh, Preparation of multiple unit hollow microspheres (microballoons) with acrylic resin containing tranilast and their drug release characteristics (in vitro) and floating behavior (in vivo), J. Controlled Release, 16, 279-290 (1991).
6. M. Ichikawa, T. Kato, M. Kawahara, S. Watanabe, and M. Kayano, A new multiple-unit oral floating dosage system, II: In vivo evaluation of floating and sustained-release characteristics with p-aminobenzoic acid and isosorbide dinitrate as model drugs, J. Pharm. Sci., 80, 1153-1156 (1991).
7. A. Ruhnke, Einfluss der Dichte von Pellets auf die Verweildauer im Magen und die Absorption eines Modell-Arzneistoffes, Ph. D. Thesis, University of Hamburg, 1989.
8. B. C. Lippold and J. Günther, In-vivo Prüfung einer multipartikulären Retard-Schwimmarzneiform, Eur. J. Pharm. Biopharm., 37, 254-261 (1991).
9. P. Colombo, U. Conte, C. Caramella, A. Gazzaniga, and A. La Manna, Compressed polymeric mini-matrices for drug release control, J. Controlled Release, 1, 283-289 (1985).
10. A. Gazzaniga, U. Conte, M. E. Sangalli, C. Caramella, and A. La Manna, A multiple unit modified release system, in Polymers in Medicine III (C. Migliaresi et al., eds.), Elsevier Science Publishers B.V., Amsterdam, 1988, pp. 201-208.
11. N. Rouge, E. T. Cole, P. Buri, and E. Doelker, Screening of the potentially excipients for floating minitablets, S. T. P. Pharma, in press (1997).
12. D. Brockmeier, H.-G. Grigoleit, H. Heptner, and B. H. Meyer, Kinetics of piretanide absorption from the gastrointestinal tract, Methods Find. Exp. Clin. Pharmacol., 8, 731-739 (1986).
13. D. Brockmeier, H.-G. Grigoleit, and H. Leonhardt, The absorption of piretanide from the gastro-intestinal tract is site-dependent, Eur. J. Clin. Pharmacol., 30, 79-82 (1986).
14. D. C. Taylor, Sites and mechanisms of intestinal drug absorption, Pharm. Int., 7, 179-183 (1986).
15. N. Rouge, P. Buri, and E. Doelker, Drug absorption sites in the gastrointestinal tract and dosage forms for site-specific delivery, Int. J. Pharm., 136, 117-139 (1996).
16. N. Rouge, J. C. Leroux, E. T. Cole, E. Doelker, and P. Buri, Prevention of the sticking tendency of the minitablets filled into hard gelatin capsules, Eur. J. Pharm. Biopharm., 43, 165-171 (1996).
17. J. Timmermans and A. J. Moës, Apparatus and method for resultant-weight measuring system, US Patent Application 5,076,107 (1991).
18. J. Timmermans, Floating hydrophilic matrix dosage forms for oral use: factors controlling their buoyancy and gastric residence capabilities, Ph.D. Thesis, University of Brussels, 1991.
19. K. Uekama, K. Matsubara, K. Abe, Y. Horiuchi, F. Hirayama, and N. Suzuki, Design and in vitro evaluation of slow-release dosage form of piretanide: utility of β-cyclodextrin: cellulose derivative combination as a modified-release drug carrier, J. Pharm. Sci., 79, 244-247 (1990).
20. C. Doherty and P. York, Mechanisms of dissolution of furosemide/PVP solid dispersions, Int. J. Pharm., 34, 197-205 (1987).
21. N. A. Peppas, Analysis of Fickian and non-Fickian drug release from polymers, Pharm. Acta Helv., 60, 110-111 (1985).
22. P. L. Ritger and N. A. Peppas, A simple equation for description of solute release. II. Fickian and anomalous release from swellable device, J. Controlled Release, 5, 37-42 (1987).
23. T. Ostberg, E. M. Lund, and C. Graffner, Calcium alginate matrices for oral multiple unit administration: IV. Release characteristics in different media, Int. J. Pharm., 112, 241-248 (1994).
24. U. Conte, L. Maggi, and A. La Manna, Swellable/erodible barriers for the modulation of drug release from hydrophilic matrices, Proc. Int. Symp. Controlled Release Bioact. Mater., 21, 60-61 (1994).
25. E. Doelker, Water-swollen cellulose derivatives in pharmacy, in Hydrogels in Medicine and Pharmacy, Vol. II: Polymers (N. A. Peppas, ed.), CRC Press, Boca Raton, FL, 1987, pp. 115-160.
26. A. F. Stockwell, S. S. Davis, and S. E. Walker, In vitro evaluation of alginate gel systems as sustained release drug delivery systems, J. Controlled Release, 3, 167-175 (1986).
27. I. Krögel and R. Bodmeier, Evaluation of the floating properties of coated drug delivery systems containing effervescent excipient, Eur. J. Pharm. Biopharm., 42, 21(1996).
28. M. J. Vazquez, R. M. Seijas, J. L. Gomez-Amoza, R. Martinez-Pacheco, C. Souto, and A. Concheiro, Influence of dissolution medium and technological variables on release of atenolol from hydrophilic hydroxypropylmethylcellulose, S. T. P. Pharma, 2, 397-403 (1992).